Search Results 1091-1100 of 16849 for monoclonal antibody

1. Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™ - Mayo Clinic

   History of severe allergic or anaphylactic reaction to monoclonal antibody therapy. Confirmed diagnosis of progressive multifocal leukoencephalopathy ...

2. Mayo Clinic Minute: How the immune system can make getting an organ transplant trickier

   Bentall says. He says it happens when a person has antibodies that cause their immune system to reject a transplanted organ. "The immune system doesn't ...

3. A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving ABBV-383 as an Intravenous (IV) Infusion - Mayo Clinic

   (dFLC) >= 50 mg/L. - Has previously been exposed to a proteasome inhibitor (PI) and an anti-CD38 monoclonal antibody. Exclusion Criteria: - Known history of ...

4. Clinical trials - Oncology (Medical)

   ... antibody (ANCA) associated vasculitis using primary samples and/or patient derived xenograft models. A Study of ONO-7475 in Patients With Acute Leukemias.

5. Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization - Mayo Clinic

   About this study. The purpose of this trial is to determine the safety and efficacy of eculizumab in the prevention of antibody mediated rejection (AMR) in ...

6. Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease - Mayo Clinic

   Prior treatment with anti-CD20 monoclonal antibody or alemtuzumab within 3 months prior to start of therapy. Uncontrolled infectious complications not ...

7. Immune globulin-hipp (subcutaneous route) - Mayo Clinic

   Description. Immune globulin-hipp injection contains antibodies that make your immune system stronger. It is used for patients who have primary humoral ...

8. Mayo Clinic researchers question effectiveness of mRNA COVID-19 vaccines for solid organ transplant patients

   Dr. Wadei and his team tested the blood of patients who had received a solid organ for spike antibodies to COVID-19, which would be the type of antibody ...

9. A Study to Evaluate RVT-1401 for the Treatment of Patients with Active, Moderate-to-severe Graves' Ophthalmopathy - Mayo Clinic

   Use of rituximab, tocilizumab, or any monoclonal antibody/Fc-fusion biologic for immunomodulation within the past 9 months prior to Baseline. Use of ...

10. Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma (PROSPECT Study) - Mayo Clinic

    Tests positive for HIV-1 antibody and HIV-2 antibody, human T-lymphotropic virus 1 antibody, HBs antigen, or HCV antibody. Tests positive for HBs antibody or ...